Duan Qi, Lyu Jinhao, Liu Ziqi, Hao Fangbin, Li Runze, Liu Simeng, Hao Xiaokuan, Li Jingjie, Bian Xianbing, Duan Caohui, Wang Song, Wang Wanbing, Wang Rong, Duan Lian, Lou Xin
Department of Radiology, the First Medical Center of Chinese PLA General Hospital, Beijing, China.
Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, China; and.
Neurology. 2025 Jun 10;104(11):e213617. doi: 10.1212/WNL.0000000000213617. Epub 2025 May 21.
While digital subtraction angiography (DSA) is traditionally used for moyamoya disease (MMD) assessment, its invasiveness and limitations necessitate alternative methods. The higher signal-to-noise ratio (SNR) and contrast-to-noise ratio of 7T MRI improve the clarity of the image and retains the details of the structures. We aimed to assess the performance of 7T MRI in identifying hemorrhagic risk features of MMD compared with 3T MRI and DSA.
This cross-sectional study recruited patients with MMD who underwent both 7T and 3T MRI scans within a 24-hour window, from March 2022 to December 2023. Patients were categorized into hemorrhagic, ischemic, and asymptomatic groups based on standard MRI findings and clinical symptoms. Corresponding DSA images acquired within 90 days were also collected as a comparative benchmark. Hemorrhage risk factors including dilatation and branch extension of the anterior choroidal artery (AChA) and posterior communicating artery (PComA) were assessed and graded on time-of-flight magnetic resonance angiography (TOF-MRA) and DSA images following established protocols. The hemorrhage locations were classified into anterior and posterior circulation groups.
A total of 180 patients (mean age, 43.95 ± 11.02 [SD] years; 53.9% female) were included in the study (hemorrhagic = 51, ischemic = 37, asymptomatic = 92). Notably, 42.4% of AChA and 27.7% of PComA anomalies detected on 7T TOF-MRA were absent on 3T imaging. The 7T TOF-MRA demonstrated a strong correlation with DSA in assessing the AChA stage (weighted κ = 0.891, < 0.001) and PComA stage (weighted κ = 0.761, < 0.001). Higher AChA (70.6% vs 21.6% vs 6.5%, < 0.001) and PComA (51.0% vs 8.1% vs 12.0%, < 0.001) grades were more common in patients with hemorrhagic MMD compared with ischemic and asymptomatic groups. In binary logistic regression analysis for hemorrhagic and ischemic groups, elevated stages of AChA (odds ratio [OR] 1.90, 95% CI 1.20-3.54, = 0.042) and PComA (OR 3.89, 95% CI 1.76-8.58, = 0.001) were associated with increased hemorrhagic risk. Furthermore, the proportion of higher AChA (62.2%, = 0.008) and PComA (51.3%, = 0.010) grades were more prevalent in cases involving both anterior and posterior circulations.
The 7T TOF-MRA visualization of dilatation and branching extension of the AChA and PComA indicates a heightened risk of hemorrhage, suggesting that this imaging technique could serve as a valuable noninvasive tool for identifying hemorrhagic vulnerabilities in MMD.
ClinicalTrials.gov, NCT05287750, Brain Diseases on 7.0T Magnetic Resonance Imaging, First Submitted January 2022. clinicaltrials.gov/study/NCT05287750.
This study provides Class II evidence that 7T-TOF MRA accurately distinguishes hemorrhagic risk in patients with MMD compared with 3T-TOF MRA and DSA.
虽然数字减影血管造影(DSA)传统上用于烟雾病(MMD)评估,但其侵入性和局限性促使人们寻求替代方法。7T MRI具有更高的信噪比(SNR)和对比噪声比,可提高图像清晰度并保留结构细节。我们旨在评估7T MRI与3T MRI和DSA相比,在识别MMD出血风险特征方面的性能。
这项横断面研究招募了在2022年3月至2023年12月期间24小时内接受7T和3T MRI扫描的MMD患者。根据标准MRI表现和临床症状,将患者分为出血组、缺血组和无症状组。还收集了90天内获得的相应DSA图像作为比较基准。按照既定方案,在时间飞跃磁共振血管造影(TOF-MRA)和DSA图像上评估并分级包括脉络膜前动脉(AChA)和后交通动脉(PComA)扩张及分支延伸在内的出血危险因素。出血部位分为前循环组和后循环组。
本研究共纳入180例患者(平均年龄43.95±11.02[标准差]岁;53.9%为女性)(出血组=51例,缺血组=37例,无症状组=92例)。值得注意的是,7T TOF-MRA检测到的AChA异常中有42.4%、PComA异常中有27.7%在3T成像上未显示。7T TOF-MRA在评估AChA分期(加权κ=0.891,P<0.001)和PComA分期(加权κ=0.761,P<0.001)方面与DSA显示出很强的相关性。与缺血组和无症状组相比,出血性MMD患者中较高的AChA分级(70.6%对21.6%对6.5%,P<0.001)和PComA分级(51.0%对8.1%对12.0%,P<0.001)更为常见。在出血组和缺血组的二元逻辑回归分析中,AChA分期升高(比值比[OR]1.90,95%可信区间1.20 - 3.54,P=0.042)和PComA分期升高(OR 3.89,95%可信区间1.76 - 8.58,P=0.001)与出血风险增加相关。此外,在涉及前循环和后循环的病例中,较高的AChA分级(62.2%,P=0.008)和PComA分级(51.3%,P=0.010)更为普遍。
7T TOF-MRA对AChA和PComA扩张及分支延伸的可视化表明出血风险增加,提示该成像技术可作为识别MMD出血易感性的有价值的非侵入性工具。
ClinicalTrials.gov,NCT05287750,7.0T磁共振成像上的脑部疾病,首次提交于2022年1月。clinicaltrials.gov/study/NCT05287750。
本研究提供了II类证据,表明与3T-TOF MRA和DSA相比,7T-TOF MRA能准确区分MMD患者的出血风险。